What is a stock summary page? Click here for an overview.
Business Description
ITeos Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US46565G1040
Share Class Description:
ITOS: Ordinary SharesDescription
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 97.07 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.53 | |||||
| Beneish M-Score | -1.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -54.4 | |||||
| 3-Year Book Growth Rate | 1.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | -44.26 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.39 | |||||
| 9-Day RSI | 25.04 | |||||
| 14-Day RSI | 29.03 | |||||
| 3-1 Month Momentum % | -15.95 | |||||
| 6-1 Month Momentum % | -31.64 | |||||
| 12-1 Month Momentum % | -44.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.62 | |||||
| Quick Ratio | 12.62 | |||||
| Cash Ratio | 12.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1 | |||||
| Shareholder Yield % | -59.04 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -440.93 | |||||
| Net Margin % | -384.04 | |||||
| FCF Margin % | -285.18 | |||||
| ROE % | -22.39 | |||||
| ROA % | -19.43 | |||||
| ROIC % | -107.54 | |||||
| 3-Year ROIIC % | 345.49 | |||||
| ROC (Joel Greenblatt) % | -1442.22 | |||||
| ROCE % | -23.58 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 6 | |||||
| PB Ratio | 0.33 | |||||
| Price-to-Tangible-Book | 0.33 | |||||
| EV-to-EBIT | 1.76 | |||||
| EV-to-EBITDA | 1.78 | |||||
| EV-to-Revenue | -7.77 | |||||
| EV-to-Forward-Revenue | 1.43 | |||||
| EV-to-FCF | 2.73 | |||||
| Price-to-GF-Value | 1.58 | |||||
| Price-to-Net-Current-Asset-Value | 0.48 | |||||
| Price-to-Net-Cash | 0.5 | |||||
| Earnings Yield (Greenblatt) % | 56.82 | |||||
| FCF Yield % | -48.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ITOS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ITeos Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 35 | ||
| EPS (TTM) ($) | -3.33 | ||
| Beta | 1.14 | ||
| 3-Year Sharpe Ratio | -0.6 | ||
| 3-Year Sortino Ratio | -0.82 | ||
| Volatility % | 81.78 | ||
| 14-Day RSI | 29.03 | ||
| 14-Day ATR ($) | 0.342174 | ||
| 20-Day SMA ($) | 6.713 | ||
| 12-1 Month Momentum % | -44.94 | ||
| 52-Week Range ($) | 5.32 - 18.75 | ||
| Shares Outstanding (Mil) | 38.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ITeos Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ITeos Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ITeos Therapeutics Inc Frequently Asked Questions
What is ITeos Therapeutics Inc(ITOS)'s stock price today?
The current price of ITOS is $5.39. The 52 week high of ITOS is $18.75 and 52 week low is $5.32.
When is next earnings date of ITeos Therapeutics Inc(ITOS)?
The next earnings date of ITeos Therapeutics Inc(ITOS) is 2025-05-09 Est..
Does ITeos Therapeutics Inc(ITOS) pay dividends? If so, how much?
ITeos Therapeutics Inc(ITOS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers